CUSIP: 849431101
Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,953,989
-
Share change
-
-5,359
-
Total reported value
-
$3,955,000
-
Price per share
-
$1.34
-
Number of holders
-
22
-
Value change
-
-$19,056
-
Number of buys
-
7
-
Number of sells
-
8
Quarterly Holders Quick Answers
What is CUSIP 849431101?
CUSIP 849431101 identifies SBPH - SPRING BK PHARMACEUTICALS IN - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2020
-
Previous quarter:
Q2 2020
Recent filing periods for CUSIP 849431101:
Institutional Holders of SPRING BK PHARMACEUTICALS IN - COM (SBPH) as of Q3 2020
As of 30 Sep 2020,
SPRING BK PHARMACEUTICALS IN - COM (SBPH) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,953,989 shares.
The largest 10 holders included
BVF INC/IL, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, TIEDEMANN ADVISORS, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, PARSONS CAPITAL MANAGEMENT INC/RI, Private Capital Advisors, Inc., and SILVERCREST ASSET MANAGEMENT GROUP LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.